MMC Now Offers Advanced PSMA-PET Imaging for Men with Prostate Cancer

Learn More

(Las Cruces, NM – December 16, 2024) – In conjunction with its new full-time PET/CT unit, Memorial Medical Center now offers cutting-edge PSMA-PET imaging for men with prostate cancer. This innovative technology is available for identifying and locating prostate cancer in men whose cancer may have spread to other parts of the body and may need initial therapy, or whose cancer may have come back based on elevated serum prostate-specific antigen (PSA) levels.

A PET scan with Illuccix can reveal the presence of prostate cancer cells throughout the body and may be able to detect tumors more accurately than conventional imaging methods. MMC is the only facility in Southern New Mexico offering the Illuccix technology.

More than 3.1 million men are living with prostate cancer in the United States. Prostate cancer continues to pose a significant health challenge, ranking as the second leading cause of cancer death among men. Delayed diagnosis can result in fewer treatment options and increased mortality risk.

Ongoing PSA screenings and access to advanced imaging such as a PSMA-PET scan with Illuccix are crucial factors for early detection and accurate diagnosis. Illuccix may be able to detect cancer when PSA levels are low, when tumors are small, or when conventional imaging results are uncertain.

“PSMA-PET/CT technology is a breakthrough in prostate cancer diagnosis,” said Memorial Cancer Center Radiation Oncologist Jason Call, MD. “Understanding the extent of the disease is crucial in determining the appropriate treatment. A PSMA-PET scan can provide the precision and reliability required to guide treatment decisions for my patients.”

Memorial Medical Center is dedicated to staying at the forefront of medical technology to provide the best possible healthcare to Las Cruces and beyond.